Window of Opportunity Study in Colorectal Cancer

NCT03984578 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: CAPEOX
DRUG: Pembrolizumab
DRUG: Capecitabine/ 5-FU
DRUG: Pembrolizumab
DRUG: CAPEOX/Pembrolizumab
DRUG: Pembrolizumab alone
PROCEDURE: Surgical resection

Sponsor

National Cancer Centre, Singapore

Collaborators

[object Object]